Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices

In line with the WHO recommendations and guidance issued in April 2020, USAID advised Act | West to temporarily suspend NTD field activities. A temporary suspension of activities provided time for national programs, with the support of Act | West implementing partners, to develop risk assessment tools and processes, standard operating procedures to limit SARS-CoV-2 transmission during activities, and weigh the risks and benefits of restarting activities.

Restarting NTDPs in West Africa during the COVID-19 Pandemic_ Lessons Learned and Best Practices.pdf

Kabore, A., Palmer, S. L., Mensah, E., Ettiegne-Traore, V., Monteil, R., Sintondji, F., Tine, J., Tesfaye, D., Ogoussan, K., Stukel, D., Fuller, B. B., Sanchez, K., Pou, B., Dembele, B., Weaver, A., Reid, S., Milord, M. D., Kassankogno, Y., Seim, A., & Shott, J. (2021). Restarting Neglected Tropical Diseases Programs in West Africa during the COVID-19 Pandemic: Lessons Learned and Best Practices, The American Journal of Tropical Medicine and Hygiene105(6), 1476-1482. https://www.ajtmh.org/view/journals/tpmd/105/6/article-p1476.xml

Line graph figure from article
Type
Journal Article
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
FHI360